These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6772365)

  • 1. Cell-mediated cytotoxicity to Trypanosoma cruzi. I. Antibody-dependent cell mediated cytotoxicity to trypomastigote bloodstream forms.
    Okabe K; Kipnis TL; Calich VL; Dias da Silva W
    Clin Immunol Immunopathol; 1980 Jul; 16(3):344-53. PubMed ID: 6772365
    [No Abstract]   [Full Text] [Related]  

  • 2. Destruction of Trypanosoma cruzi by Natural killer cells.
    Hatcher FM; Kuhn RE
    Science; 1982 Oct; 218(4569):295-6. PubMed ID: 6812218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma cruzi: immune destruction of parasitized mouse fibroblasts in vitro.
    Kuhn RE; Murnane JE
    Exp Parasitol; 1977 Feb; 41(1):66-73. PubMed ID: 402286
    [No Abstract]   [Full Text] [Related]  

  • 4. Trypanosoma cruzi: the fate of bloodstream trypomastigote, amastigote, metacyclic trypomastigote and epimastigote forms in the peritoneal macrophages of immune and non-immune mice in vivo.
    Burger E; Lay WH; Hypolito LV; Fernandes JF
    Acta Trop; 1982 Jun; 39(2):111-22. PubMed ID: 6126093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral antibody response in mice infected with Trypanosoma cruzi.
    Cardoni RL; Rimoldi MT; Esteva M; de Bracco MM
    Medicina (B Aires); 1986; 46(4):435-9. PubMed ID: 3106748
    [No Abstract]   [Full Text] [Related]  

  • 6. Killing of circulating forms of Trypanosoma cruzi by lymphoid cells from acutely and chronically infected mice.
    Kierszenbaum F; Gharpure HM
    Int J Parasitol; 1983 Aug; 13(4):377-81. PubMed ID: 6413441
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody dependent cell-mediated cytotoxicity against Trypanosoma cruzi.
    Abrahamsohn IA; Silva WD
    Parasitology; 1977 Dec; 75(3):317-23. PubMed ID: 415286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of antibody dependent cytotoxicity to Trypanosoma cruzi in chronic chagasic mice after treatment with nifurtimox.
    Chambó JG; Cabeza Meckert PM; Laguens RP
    Medicina (B Aires); 1988; 48(1):49-53. PubMed ID: 3146009
    [No Abstract]   [Full Text] [Related]  

  • 9. Protein fraction from Trypanosoma cruzi infected spleen cell supernatants with immunosuppressive activity in vitro.
    Serrano LE; O'Daly JA
    Int J Parasitol; 1987 Feb; 17(3):851-61. PubMed ID: 3106254
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiheart antibody-dependent cytotoxicity in the sera of mice chronically infected with Trypanosoma cruzi.
    Laguens RP; Meckert PC; Chambó JG
    Infect Immun; 1988 Apr; 56(4):993-7. PubMed ID: 3126153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 75Se-methionine labelled Trypanosoma cruzi blood trypomastigotes: opsonization by chronic infection serum facilitates killing in spleen and liver.
    Scott MT; Moyes L
    Clin Exp Immunol; 1982 Jun; 48(3):754-7. PubMed ID: 6811174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
    Wallace A; Sanchez G; Venegas J; Solari A
    Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent cytolysis of Trypanosoma cruzi by human polymorphonuclear leukocytes.
    Olabuenaga SE; Cardoni RL; Segura EL; Riera NE; de Bracco MM
    Cell Immunol; 1979 Jun; 45(1):85-93. PubMed ID: 110466
    [No Abstract]   [Full Text] [Related]  

  • 14. One fate of bloodstream trypomastigote forms of Trypanosoma cruzi after immune clearance: an ultrastructural study.
    Umekita LF; Carneiro SM; Sesso A; Mota I
    J Parasitol; 1999 Oct; 85(5):867-72. PubMed ID: 10577722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune response in Trypanosoma cruzi infection].
    Rottenberg ME; de Titto EH; Cardoni RL; Segura EL
    Rev Argent Microbiol; 1991; 23(2):101-21. PubMed ID: 1815267
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lytic antibodies elicited by Trypanosoma cruzi infection recognize epitopes present on both bloodstream trypomastigote and epimastigote forms of parasite.
    Takehara HA; Cardoso DF; da Silva AM; Mota I
    Rev Inst Med Trop Sao Paulo; 1988; 30(5):351-6. PubMed ID: 2471248
    [No Abstract]   [Full Text] [Related]  

  • 18. Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis.
    Krettli AU; Weisz-Carrington P; Nussenzweig RS
    Clin Exp Immunol; 1979 Sep; 37(3):416-23. PubMed ID: 116784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface glycoproteins of Trypanosoma cruzi: protective immunity in mice and antibody levels in human chagasic sera.
    Snary D
    Trans R Soc Trop Med Hyg; 1983; 77(1):126-9. PubMed ID: 6407157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi: effect on B-cell-responsive and -responding clones.
    Cunningham DS; Kuhn RE; Tarleton RL; Dunn RS
    Exp Parasitol; 1981 Apr; 51(2):257-68. PubMed ID: 6781919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.